共 196 条
- [1] Bartalena L(2016)Management of hyperthyroidism due to Graves’ disease: frequently asked questions and answers (if any) J Endocrinol Invest 39 1105-1114
- [2] Chiovato L(2012)A 2011 survey of clinical practice patterns in the management of Graves’ disease J Clin Endocrinol Metab 97 4549-4558
- [3] Vitti P(2004)Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis Thyroid 14 459-462
- [4] Burch HB(2005)Antithyroid drugs N Engl J Med 352 905-917
- [5] Burman KD(2005)Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy? Thyroid 15 292-297
- [6] Cooper DS(2012)Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves’ disease J Clin Endocrinol Metab 97 E49-E53
- [7] Tajiri J(2013)Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan J Clin Endocrinol Metab 98 4776-4783
- [8] Noguchi S(2016)Antithyroid drug side effects in the population and in pregnancy J Clin Endocrinol Metab 101 1606-1614
- [9] Cooper DS(1998)Fever or a soar throat after start of antithyroidal drugs? A medical emergency Neth J Med 53 113-117
- [10] Tajiri J(1999)Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections QJM 92 455-46112